Tenet Healthcare officer acquires shares via RSU vesting

Tenet Healthcare’s Principal Accounting Officer, Ramsey R. Scott, reported acquiring shares through the vesting of restricted stock units.

Rhea-AI Filing Summary

Tenet Healthcare’s Principal Accounting Officer, Ramsey R. Scott, reported acquiring shares through the vesting of restricted stock units. On February 24, 2026, 443 restricted stock units converted into 443 shares of common stock at a price of $0.00 per share. Following this derivative exercise, Scott directly owned 9,891 shares of common stock and 888 restricted stock units. The units were granted under the 2019 Stock Incentive Plan, vesting in three equal annual installments, with the first third vesting on February 24, 2026 and settled in common stock.

Insider Trade Summary

443 shares exercised/converted

Exercise 2 txns

Insider Ramsey R. Scott

Role Principal Accounting Officer

Type	Security	Shares	Price	Value
Exercise	2025 Restricted Stock Units	443	$0.00	$0.00
Exercise	Common Stock	443	$0.00	$0.00

Holdings After Transaction: 2025 Restricted Stock Units — 888 contracts (Direct); Common Stock — 9,891 shares (Direct)

Footnotes (3)

1. F1. Restricted stock units convert into common stock on a one-for-one basis.
2. F2. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2025, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on February 24, 2026.
3. F3. Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Tenet Healthcare (THC) report for Ramsey R. Scott?

Tenet Healthcare reported that Principal Accounting Officer Ramsey R. Scott acquired shares via restricted stock units. On February 24, 2026, 443 units converted into 443 common shares at $0.00, reflecting vesting of equity compensation rather than an open-market stock purchase.

How many Tenet Healthcare (THC) shares does Ramsey R. Scott own after this Form 4?

After the reported transactions, Ramsey R. Scott directly owns 9,891 shares of Tenet Healthcare common stock. He also holds 888 restricted stock units, which represent additional potential shares that may be delivered as they vest under the company’s 2019 Stock Incentive Plan.

What was the price per share in Ramsey R. Scott’s recent Tenet Healthcare (THC) transaction?

The transaction price per share was reported as $0.00 because the shares came from restricted stock units vesting, not a cash purchase. These equity awards convert into common stock on a one-for-one basis when vesting conditions under the 2019 Stock Incentive Plan are met.

What are the vesting terms of Ramsey R. Scott’s 2025 Tenet Healthcare (THC) restricted stock units?

The 2025 restricted stock units were granted on February 24, 2025 and vest in three equal annual installments. The first one-third vested on February 24, 2026. Upon each vesting date, time-based restricted stock units are settled in shares of Tenet Healthcare common stock.

Did Ramsey R. Scott buy or sell Tenet Healthcare (THC) shares on the open market?

The Form 4 shows no open-market buys or sells. Instead, Scott acquired shares through a derivative exercise, where 443 restricted stock units automatically converted into 443 common shares upon vesting, consistent with the company’s equity compensation plan terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/26/2026 - 08:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ramsey R. Scott

(Last) (First) (Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS TX 75254

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Principal Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/24/2026		M		443	A	(1)	9,891	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
2025 Restricted Stock Units	(2)	02/24/2026		M			443	(2)	(2)	Common Stock(3)	443	$0	888	D

Explanation of Responses:

1. Restricted stock units convert into common stock on a one-for-one basis.

2. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2025, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on February 24, 2026.

3. Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.

	Chad J. Wiener, as Attorney-in-fact for R. Scott Ramsey	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.